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Negative values are in favor of VMAT plans. *: difference is 
statistically significant (p<0.05). 
Conclusions: For the liver patients, the automatically 
generated dual-arc VMAT plans are substantially better than 
the manually generated non-coplanar CK plans, while 
requiring no workload. In addition, delivery times with VMAT 
are much shorter. 
 
PO-0915   
Dosimetric and clinical predictors of late urinary symptoms 
after radical radiation therapy for prostate cancer  
T. Rancati1, F. Palorini2, C. Cozzarini3, N. Bedini4, V. 
Casanova Borca5, C. Degli Esposti6, G. Girelli7, M. 
Palombarini8, A. Pierelli9, E. Pignoli10, V. Vavassori11, R. 
Valdagni12, C. Fiorino13 
1Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate 
Cancer Program, Milan, Italy  
2San Raffaele Scientific Institute, Medical Physics, Milan, 
Italy  
3San Raffaele Scientific Institute, Radiotherapy, Milan, Italy  
4Fondazione IRCCS Istituto Nazionale dei Tumori, Radiation 
Oncology 1, Milan, Italy  
5Ospedale ASL9, Medical Physics, Ivrea, Italy  
6Ospedale Bellaria, Radiotherapy, Bologna, Italy  
7Ospedale ASL9, Radiotherapy, Ivrea, Italy  
8Ospedale Bellaria, Medical Physics, Bologna, Italy  
9Cliniche Gavazzeni-Humanitas, Medical Physics, Bergamo, 
Italy  
10Fondazione IRCCS Istituto Nazionale dei Tumori, Medical 
Physics, M ilan, Italy  
11Cliniche Gavazzeni-Humanitas, Radiotherapy, Bergamo, 
Italy  
12Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate 
Cancer Program and Radiation Oncology 1, M ilan, Italy  
13San Raffaele Scientific Institute, Medical Physics, M ilan, 
Italy  
 
Purpose/Objective: A prospective observational study 
started in 2010 with the goal of developing predictive models 
of urinary (UR) toxicity (tox) and of erectile dysfunction after 
high dose radical radiotherapy (RT) for prostate cancer. Aim 
of this ad-interim analysis was to assess correlations between 
incidence of UR symptoms (symps) in the first 18 months 
(mos) after RT completion (as measured by the International 
Prostate Symptom Score, IPSS) and clinical/dosimetric risk 
factors.  
Materials and Methods: The trial included patients (pts) 
treated with conventional fractionation (74-80Gy at 1.8-
2Gy/fr) or moderate hypofractionation (65-75.2Gy at 2.2-
2.7Gy/fr), 5 fr/week. Prospectively collected clinical factors: 
T stage, comorbidities, drugs, androgen deprivation (AD), 
previous surgeries, smoking, alcohol, age, BMI. Bladder DVHs 
were corrected with alfa/beta=3Gy. IPSS was prospectively 
filled in at start/end of RT, at 3 and 6 mos follow-up (fup) 
and every 6 mos thereafter, till 5 yrs fup. We here 
considered an IPSS≥15 in the first 18 mos after RT completion 
as the UR tox endpoint (onset of moderate-severe UR symp), 
end RT IPSS was excluded, as relating to tox during RT. 
Analysis was accomplished for whole population and for 
subgroup with basal IPSS<15. A multivariate logistic 
regression (MVR) was performed. Choice of relevant factors 
to be included was carried out through an in-silico 
methodology combining bootstrap resampling, backward 
feature selection based on minimization of residuals and 
basket/network analysis of bootstrapped models. The 
features with the greatest % of occurrences (OCC) in the 
bootstrapped models were included in MVR. KNIME software 
was used. 
Results: By Nov 2014, 542 pts were enrolled. 
Clinical/dosimetric/endpoint data (18mos) available for 211 
pts, minimum fup 18mos. Incidence of IPSS≥15: 44/211 (21%) 
in the whole population and 34/193 (18%) in pts with basal 
IPSS<15. A 4-variable model was considered (AUC=0.81, CI 
0.75-0.86) including: basal IPSS (continuous variable, OR=1.2, 
OCC=98%), bladder volume receiving >78Gy (V78Gy, cont var, 
OR=1.09, OCC=69%), age (cont var, OR=1.05, OCC=34%) and 
diabetes (OR=2.7, OCC=20%). The model was confirmed for 
pts with basal IPSS<15 (AUC=0.79). 
Figure panel (a) shows %OCC of risk factors in 500 
simulations, while panel (b) reports rates of IPSS≥15 as a 
function of V78Gy. Minimizing V78Gy has a relevant impact 
on lowering toxicity incidence. ROC analysis suggests a cutoff 
V78Gy=6% (15% vs 34% UR tox below/above cutoff) 
 
Conclusions: Ad interim analysis shows an important 
correlation between UR tox at 18mos fup and bladder V78Gy, 
a cutoff V78Gy=6% can be suggested. Basal IPSS, age and 
diabetes act as modifiers of dose-response relationship (risk 
factors). Due to the timing of onset of late radioinduced UR 
toxicity (incidence increasing till 5yr fup), this interesting 
result has to be confirmed when longer fup will be available.  
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Purpose/Objective: Radiotherapy (RT) of lung cancer 
patients could be improved if patient specific dose tolerances 
can be estimated during the first weeks of a fractionated 
treatment course. Such tolerances may be estimated from 
the delivered dose distribution and changes in ventilation and 
respiration patterns extracted from frequently recorded 4D-
Cone Beam CT. 
Materials and Methods: This is a study of 140 non-small-cell 
lung cancer (NSCLC) patients, which were treated with 60-66 
Gy in 30-33 fractions. Measures of ventilation were generated 
by the freeware tool elastix (http://elastix.isi.uu.nl/), which 
was used for deformable registrations between inspiration 
phases and expiratory phases as well as calculation of 
Jacobian determinant images of Elekta XVI 4D-CBCT 
reconstructions. Approximately 3000 recorded XVI scans were 
available for this study group. The mean of the Jacobian 
determinant (MJD) within the healthy lung region was used as 
a measure of the overall lung ventilation during the 
treatment course. Amsterdam Shrouds of the 4D-CBCT 
projections were generated by RTK-software, and the 
respiratory period (ReP) was estimated from the extracted 
respiratory signal. For each patient the slope of linear fits of 
MJD and ReP values vs. fraction number for the first 10 
fractions as well as for the full number of fractions were used 
as measures for ventilation and respiration changes during 
RT. Relative changes (after/before-1) in forced expiratory 
volume in 1 second (FEV1) and forced expiratory vital 
capacity (FVC) before and after the treatment course were 
chosen as clinical endpoints (ΔFEV1 REL and ΔFVCREL). 
A multivariable analysis was performed on ΔFEV1 REL and 
ΔFVCREL respectively as dependent variables with the co-
variables MJD-slope, ReP-slope and mean lung dose (MLD). 
Results: The deformable registrations and calculating MJDs as 
well as estimating RePs from Amsterdam Shrouds were 
carried out successfully for all the 140 patients. In the 
multivariable analysis only MLD was significant in relation to 
ΔFEV1 REL and ΔFVCREL  
(ΔFEV1 REL=-0.006MLD+0.078; pMLD=0.009 and ΔFVCREL=-
0.008MLD+0.115; pMLD=0.002, respectively). Plots of ΔFEV1 REL 
and ΔFVCREL as a function of MLD are shown in the figure. 
Both plots show a declining tendency, indicating that higher 
MLD corresponds to larger decrease in clinically measured 
lung function tests. Spearman correlation coefficient 
between ΔFEV1 REL and ΔFVCREL versus mean lung dose were -
0.249 (p=0.003) and -0.252 (p=0.003), respectively. 
 
Conclusions: In this study it was possible to carry out the 
deformable registrations on the 4D-CBCT-scans, but for the 
current 4D-CBCTimage quality, it was not possible to show an 
association between changes in mean Jacobian or respiration 
period during RT with changes in FEV1 and FVC. 
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Purpose/Objective: Genitourinary (GU) toxicity following 
radiotherapy (RT) for prostate cancer involves the interplay 
between various symptoms. Commonly used toxicity scoring 
systems capture a subset of GU symptoms only. The purpose 
of this study was to investigate the wider range of GU 
toxicity as reported by patients (atomized patient-reported 
outcomes), how such symptoms interact, and to what extent 
their occurrence can be explained by the urinary bladder 
dose. 
Materials and Methods: We applied factor analysis (FA) to 
group 35 patient-reported GU symptoms in four prostate 
cancer cohorts (N=1009). The investigated cohorts included 
patients that were previously treated for localized prostate 
cancer with either primary or salvage external beam RT 
(EBRT), or EBRT combined with brachytherapy at two centres 
during 1993-2007 (time to follow-up: 1-14 years; average age 
at RT: 64-70 years). Prescribed dose was 70-78 Gy in 2 Gy 
fractions. Relationships between maximum or mean absorbed 
dose (Dmax or Dmean; population median of Dmean: 49-54 Gy) to 
the urinary bladder and single/joint symptoms in the 
identified symptom groups were investigated for patients 
treated with primary EBRT using logistic regression and 
receiver operating curve analysis, quantifying the area under 
the curve (Az). 
Results: Three distinct symptom groups, labelled 
Incontinence, Obstruction, and Urgency were consistently 
identified across all cohorts. For patients treated with 
primary EBRT, Dmax predicted multiple joint symptoms of 
Urgency (p=0.02; Az=0.73), and one single or two joint 
